The 'cascade of care' construct is increasingly used in public health to map the trajectory of local HIV epidemics and of different HIV populations. The notion of 'patient engagement' is key to the progress of people living with HIV through the various 'steps' of the cascade as currently conceptualised. The public health literature on the definition, measurement, and interpretation of cascade of care frameworks is growing in parallel with critical social science literature analysing patient engagement through the lenses of 'patient citizenship' theories. In this paper, we review qualitative literature on HIV treatment, adherence to antiretroviral therapy, and care engagement that draws upon the interlinked concepts of therapeutic and biological citizenship. We aim to offer a critique of the cascade of care construct using empirical data from research studies published since 2005 that were influenced by these two concepts. In so doing, the paper places public health literature on the cascade of care in dialogue with in-depth qualitative and ethnographic approaches, to unpack the understandings and processes shaping patient engagement in HIV treatment and care in different settings. The paper also examines the contributions and limitations of the concepts of biological and therapeutic citizenship as argued by a number of scholars here reviewed.
INTRODUCTION
The HIV treatment 'cascade of care' envisages 'treated HIV' as the end point of a process of sequential care engagements -from HIV testing, to diagnosis, to linkage and access to antiretroviral treatment (ART), to retention in treatment -sufficient to bring about viral suppression (Mugavero, Amico, Horn and Thompson, 2013) . The cascade creates a framework for generating step-wise estimates of intervention access, coverage, adherence, retention, and outcome at national and regional level (Kozak, Zinski, Leeper, Willig and Mugavero, 2013; MacCarthy et al., 2015) . Such a framework provides an overview of key indicators (diagnosed and undiagnosed infections; numbers on or off treatment) and their public health implications, and offers a surveillance grid for monitoring patient dis/engagement through the pathways of care. The cascade construct thus tends to define HIV care (and its success or failure) narrowly in relation to the ultimate benchmark of viral suppression, resulting from patients being sufficiently and appropriately engaged through each of its steps.
With 'treated HIV' dependent upon patient engagement, HIV treatment is inevitably a political process. Discourses of the care cascade imply certain kinds of patient expectation and responsibility. An extensive body of extant literature accentuates how social and environmental factors shape HIV treatment provision and engagement (Gari et al., 2013; Merten et al., 2010; Underwood, Hendrickson, Van Lith, Kunda, and Mallalieu, 2014) . Additionally, critical perspectives in the social sciences have reflected upon HIV and its care as constituted through situated health practices, identities and subjectivities, with implications for different social and political contexts Whyte, 2009 ).
Much of this empirical work is qualitative in orientation and has focused on: experiential accounts of life with HIV (often contrasted to 'biomedical' articulations) (e.g. Davis, Frankis and Flowers, 2006; Persson, 2013) ; the 'identity' work involved in reconstructing life around an HIV diagnosis and related treatment (e.g. Baumgartner and David, 2009; Flowers, Davis, Larkin, Church, and Marriott, 2011) ; the gendered dimensions of HIV and health-seeking behaviours (also in combination with other social categories) (e.g. Doyal, 2009) ; and the biopolitical aspects of HIV care and the 'making' of HIV patient citizenship. This latter domain is our primary concern here, and draws heavily upon the linked theoretical frameworks of biological and therapeutic citizenship .
Conscious of the parallel developments in HIV care literatures in public health and social sciencewhich characterise HIV and its treatment as a biomedical product of the care cascade on the one hand, and critique how this politically constructs a certain patient citizenship and HIV identity on the other -we aim to track the use and development of notions of 'biological' and 'therapeutic' citizenship applied to the field of HIV treatment. In doing so, we will assess the relevance of these theoretical contributions to understanding current paradigms in HIV care, including in relation to the concept of the care cascade in the era of 'treatment-as-prevention' (Gardner, McLees, Steiner, Del Rio and Burman, 2011) . By reflecting on the primarily epidemiological notion of the HIV care cascade through a synthesis of published social science studies investigating how the HIV care process shapes the making of patient-citizens, we hope to bridge these bodies of knowledge. In so doing, we aim to emphasise the particular contribution that critical, and in-depth qualitative, social research makes to the understanding of dynamics of HIV care engagement.
HIV treatment engagement and the 'care cascade'
An undetectable HIV viral load in the blood significantly reduces the chances of HIV being transmitted (Cohen et al., 2011; World Health Organisation [WHO] , 2014). In the 'treatment-asprevention' era, measuring HIV viral load to indicate ART impact is central to definitions of what constitutes 'HIV health' and also to projecting the trajectory of HIV epidemics (Gardner et al., 2011; Hull, Wu and Montaner, 2012; May et al., 2014) . 'HIV care' itself is thus increasingly envisaged as this progressive continuum (De Cock, 2014; Mugavero et al., 2013; Nachega et al., 2014) .
In the continuum, quantitative indicators monitor the number of people who are: living with HIV; HIV tested; linked into care post-diagnosis; started on ART; on treatment; and with an undetectable viral load (MacCarthy et al., 2013; Kozak et al., 2013) . Patient engagement is key to the seamless progression through the cascade, from deciding to test, following up appointments, agreeing to start and adhering to ART until the virus is suppressed and undetectable in the blood. Patient engagement needs therefore to be 'managed' to minimise disruption to the care cascade, untreated infections and onward transmissions (Nachega et al., 2014) . Progression to a state of 'treated HIV' pivots on the capacity of services to attract and retain patients, and on patients' commitment to 'actively' access these in return.
However, there are three immediately visible limitations to the cascade concept. First, the narrow focus on viral load progression (from detectable to undetectable) detracts attention from the broader aspects of HIV as a health and social condition, and not only a virus. 'Treated HIV' represented as a product of the care cascade is blind to the complex of individual and social practices, which situate HIV and its care relative to wider definitions of 'health'. Second, viral suppression is not a 'goal' that needs to be reached, but rather a 'state' that must be maintained over time via ongoing systemic care provision coupled with continuous patient re-engagement. System-and patient-components and relations are clearly susceptible to multiple changes. Third, by delineating the accomplishment of viral suppression as and for public health control, the cascade distinguishes success and failure, of services and patients alike, in stark biomedical terms.
Against an increasing shift towards ART envisaged as 'prevention', the concept of the care cascade may thus serve to accentuate further what some have termed the 're-medicalisation' of HIV (de Wit, Aggleton, Myers and Crew, 2011; Nguyen, Bajos, Dubois-Arber, O'Malley and Pirkle, 2011) . 'HIV health' is increasingly reduced to clinical markers of ART effect, whilst patient engagement in HIV care is reduced to specific measures of ART adherence. The discourse and practices of the care cascade thus underpin a very particular biomedical constitution of HIV patient-citizens.
Antiretroviral therapy and patient citizenship
The history of the HIV/AIDS pandemic is inextricably linked to global activism from people living with HIV/AIDS and the deployment of large funding for a global humanitarian response through a complex apparatus of transnational and non-governmental organisations ). Political and humanitarian movements have been built around the biological condition of HIV infection, and are implicated in radical transformations of the relationship between people living with HIV and the state. Key here, are developments in HIV medicine and antiretroviral treatments. Although historically accompanied by struggles for broader health, economic, social and legal rights, demands for treatment development and access have increasingly taken centre-stage in what has been termed a 'political economy of pharmaceuticals' (Biehl, 2007, p. 10) .
The unique and mutual constitution of transnational, biomedical and biopolitical claims based on an individual yet shared biological condition has meant that AIDS activism first, and HIV/AIDS humanitarian interventions later, have been positioned as new forms of citizenship, biological and therapeutic respectively . From the mid-2000s onwards, notions of citizenship have informed analyses of HIV and treatment engagement, as well as of other health conditions Rhodes, Harris and Martin, 2013) .
Drawing from Petryna's (2002) original research tracing how biology and illness were implicated in citizenship claims to compensation made by Chernobyl inhabitants, propose 'biological citizenship' as the historical citizenship project of the contemporary era that "links conceptions of citizens to beliefs about the biological existence of human beings" (p. 440). In the biological citizenship project, the citizen holds specific individual rights and responsibilities towards his or her own health, and the health of society and future generations too. As a form of governing, biological citizenship is at once prescribed top-down from the state (and biomedicine) to citizens (and patients) and co-and-re-produced horizontally and relationally amongst citizens themselves, as they share a common biological trait or condition. Biological citizens are thus simultaneously governed subjects and active and engaged, including in forms of alliance with or resistance to biomedicine, science and state regulations as they pertain their health condition.
Expanding on the concept of biological citizenship to encompass the global health and humanitarian response to HIV/AIDS, Nguyen proposes the concept of 'therapeutic citizenship' as a series of "claims made on global social order on the basis of a therapeutic predicament" (2005, p. 126) . Based on ethnographic work spanning the early days of the AIDS epidemic and the introduction of ARV programmes in West Africa, Nguyen argues that a global AIDS industry increasingly entangled with the development industry and with humanitarian intervention has effectively created new subjectivities and "life forms: AIDS activism, resistant viruses, and therapeutic citizens" (Nguyen, 2005, p. 126) . The therapeutic citizenship project he describes in West Africa is supported by a 'vanguard' of local activists , fashioned through 'confessional technologies' in peersupport groups (Nguyen, 2010, pp. 35-50 ) modelled on early (US) gay activism, evangelical movements and counselling techniques .
Through these and other 'technologies of the self' (Foucault, 1988) people living with HIV and AIDS in resource-scarce (and treatment-scarce) settings learn to tell a certain story, and those who succeed in performing their role are 'triaged' into ART as potentially more valuable members of an emerging HIV/AIDS community (Nguyen, 2010, pp. 80-110) . Thus, ties originally intended to forge solidarity and support amongst positive members are changed by the (partial) arrival and (scarce) distribution of life-saving antiretroviral medicines through patchy services, interventions and small personal networks.
APPROACH
Conscious of the growing body of literature investigating the social dynamics of HIV treatment engagement, we explore the use of frameworks of therapeutic and biological citizenship in qualitative social science studies of HIV, HIV care and patient citizenship. In doing so, we are particularly interested in considering how such work can contribute to situating HIV treatment engagement in relation to epidemiological notions of the HIV cascade of care. The context-specificity of in-depth social research does not reduce its capacity to illuminate general global health frameworks and to document their emergence and effect. A collective synthesis of critical case studies can provide a nuanced yet integrated understanding of the making and implications of particular ways of looking at and intervening in major health issues, such as the HIV pandemic.
Given that social science literature specifically focused on the cascade of care is nascent, we began by using 'adherence' as an initial proxy to inform our search of qualitative research on HIV care engagement. This yielded 222 article abstracts and 37 article reviews of qualitative studies published since 2005. Among these were studies which had a specific interpretive emphasis that tended to use in-depth methods (multiple qualitative methods or ethnography) to explore experiences of people living with HIV, including those related to different stages of the cascade of care, and that drew upon social theories, including those related to citizenship. A total of 82 article abstracts fell into this category, and these were the 'pool' for our initial review. Two seminal essays by Paul were added early on as they provided the foundations of the concept of 'biosociality', which we were aware, from previous readings, would be at the core of biological and therapeutic citizenship theories.
Our review proceeded in two steps. First, we considered each of the 84 article abstracts for their relevance to three questions: 1) Does the article make explicit reference to concepts of biopolitics, biosociality, biological, therapeutic or health citizenship?; 2) Does the article focus on HIV treatment, adherence, care or care engagement?; and 3) Does the article use qualitative methodology empirically or offer a theoretical framework that can be used to inform such qualitative research? This led to us honing our selected articles for review to 22. Through an iterative process involving citation tracking in article bibliographies, additional searches of individual social science journals and of relevant social science books or monographs, we identified a further nine articles and book chapters meeting our criteria, for a total of 31 overall.
Second, we undertook an additional electronic search, using Medline, of journal articles published since 2005 and focused specifically on HIV and citizenship using the key words of: biological citizenship and HIV; therapeutic citizenship and HIV; health citizenship and HIV. After checking for duplicates, six were selected. Thus, a total of 37 articles and chapters (hereafter 'papers') were included.
Of the 37 papers in our review, nine were summarised, using a narrative approach, for their theoretical contribution to definitions of biological and therapeutic citizenship ( Table 1 ). The remaining 28 (Table 2) , largely empirical case studies, were synthesised using a structured approach to extract and distinguish content alongside original author interpretations. Having extracted key content and author interpretations of these 28 papers, we worked across them to produce a third level of abstraction focusing specifically on our key areas of analytical interest (engagement; adherence; patienthood; citizenship). Our summaries of content were thus coded, and re-coded, through a process of iteration, enabling the identification of key themes, which formed the basis for our synthesis.
In our synthesis, empirical findings, and the ways authors presented them, were coded in place of original excerpts of data, as many of the reviewed papers tended not to emphasise low inference description and accordingly reported little direct quotation but instead emphasised theory-informed interpretation. Boxes 1-3 present some illustrative extracts and field observations from the reviewed literature across the core themes, which shape our synthesis.
In addition to these core papers forming the basis of our synthesis, we also draw upon wider published literature, especially where it has informed the studies reviewed in the synthesis, in order to illuminate the analyses we present. Where such additional references appear in the results section, they have been marked with cf. for readers' clarity.
Emerging themes
We identified three primary thematic areas of study that form the basis of our synthesis: patient engagement (how people living with HIV engage with HIV-related knowledge and treatment intervention); therapies and politics (how HIV treatment engagements are contextualised politically, including in relation to the state); and biosociality and responsibility (how engagements with HIV and social identities and relations are mutually constituted).
PATIENT ENGAGEMENT
Patient engagement in HIV care is situated in relation to its specific social context, which shapes the multiple and competing meanings of HIV intervention to would-be patients, including how biomedical treatment opportunities are negotiated in everyday social life. In addition, there is an emphasis on exploring notions of engagement through the ways in which people living with HIV interplay with biomedical expertise, and how this shapes HIV and health identity.
'Deflecting' biomedical knowledge and practice
Side-effects linked to ART emerge as central elements of meanings of 'HIV health' and ART held by patients . Clinicians may tend to think of the immune system as the locum of the patient's health , and of ARVs as restoring and protecting the patients' strength, but side-effects of ARVs can compromise strength as experienced by the patient Box 1, extr.1) . What clinicians might conceive of as 'tolerable' side-effects, and what patients might find difficult to manage day-to-day, may differ .
Ethnographic studies report that participants may find that ART side-effects render physically demanding jobs difficult . Amongst residents of favelas in Rio de Janeiro precariously employed in manual labour ART is seen as a "luxury" because of the toll of sideeffects (Cataldo, 2008, p. 905) , whilst positive male construction workers in Milan comment that they cannot afford weakness or tiredness interfering with their work (Box 1, extr. 1-2).
Globally, treatment side-effects, dietary requirements, the need to rest and to take treatments at set times of the day all create obstacles to working activities, especially for those employed in lowpaid jobs requiring long hours of hard physical work, often at irregular times and with little flexibility . ART can thus become financially non-viable, not only because of its cost but also because of its demands, and adherence is adjusted accordingly. ART is adapted to competing requirements made upon the body, with people balancing the preservation of a 'biomedical' or 'pharmaceutical' self against a 'sideeffects free' self that is able to work .
Studies thus point to a 'situated rationality' whereby the perceived health risks of 'non-compliance' to biomedical advice may be juggled alongside securing the welfare of self, children or other dependants, including protecting damage to reputation and social position through work . In the harsh contexts of daily survival, such as that described by Mattes in Tanzania (2011) , ART adherence may become a measure of last resort to stay alive, rather than a form of proactive and ongoing self-care. Here then, people can be seen to 'manipulate' (Niehaus, 2014) or 'deflect' , rather than outright resist, biomedical knowledge and practice. Treatment engagement becomes a matter of accommodation, with the take-up of clinicians' guidance moderated according to situation (Box 1, extr.3).
In addition, O'Daniel's (2014) ethnography among poor African-American women in Midway (North Carolina, USA) shows that even in absence of side-effects, immediate problems of homelessness, destitution, and social isolation reduce space for attending to HIV health, and increase fear of stigma and of the loss of already scarce support networks. While interacting with HIV services and (mostly) adhering to HIV treatment, found that the most destitute amongst these women displayed little overt understanding of, or interest in, the progression of their HIV or their clinical outcomes (Box 1, extr. 4).
This might be described as a form of 'utilitarian' care engagement (cf. Rhodes et al., 2013) . Practices of deflection, adaptation, and relative indifference, run counter to the clinical requirements of patient engagement characterised by exemplary adherence through the 'cascade of care'. Nonetheless, the very practices which deflect biomedical treatment expectations still serve to accommodate them, and many such participants collect, store and take their medicines whenever and as much as possible . Deflected biomedicine is not a challenge to it, and often preserves its idealisation, even in social conditions that mitigate against its immediate realisation. Indeed, deflection can be simultaneously reasoned as necessity and as personal failure as patients navigate their way through competing social, material, moral and therapeutic demands.
In contrast to the 'single rationality' of 'treated HIV' as synonymous with viral suppression brought about by patients' strict adherence and responsibility towards health Niehaus, 2014; ), a 'situated rationality' of 'HIV health' envisages biomedical engagements as relational. To address what Mattes (in Tanzania) refers to as the "rationale of being problematic" (2011, p.170), patients' perspectives on ART may be appreciated as non-dichotomous, multiple and context-dependent (Box 1, extr. 5). Niehaus (in South Africa) likewise reminds us that "knowledge about sickness does not imply unswerving commitment to one set of beliefs" and "practical considerations often outweigh explanatory consistencies" (Niehaus, 2014, p. 362) . Compliance to biomedicine, Niehaus argues, is one way people may comply with one form of 'authority', alongside that of priests, healers, and older family members.
Adherence is thus a form of 'submission' susceptible to change, and which can be modified in relation to other forms of authority. Equally, seemingly 'irrational' behaviours, such as interrupting treatment , sharing antiretrovirals with others , changing doses, or using alternative medicines and healing practices (explicitly or implicitly) against clinicians' advice (Niehaus, 2014; , are ways in which people enact agency in the context of their day-to-day needs.
Qualitative longitudinal research in Serbia, for instance, illustrates how patient narratives of 'disengagement' from treatment, and even of apparent 'treatment resistance', are ways in which people act to cope with and respond to treatment access insecurity or pervasive uncertainty . At the same time, narratives of disengagement entertain the hope of a better treatment future, thus acting to deflect or defer rather than fundamentally resist engagement with biomedical practices.
Treatment literacy and expertise
Uncertainty is also a feature of biomedical scientific knowledge itself that is made evident to people living with HIV in the context of side-effects, unexpected reactions to treatment, treatment changes, and the 'failure' of therapy to restore a sense of health that is compatible with the lives people try to live Davis, Frankis and Flowers, 2006; . Treatment engagement is thus not only an accommodation to the particularities and uncertainties of social situation but also of the 'treatments' themselves, and their multiple effects. As the above case example of Serbia illustrates cf. Rhodes, Bernays, and Terzić, 2009) , 'patient adherence' to treatment is at least in part a structural effect of 'state adherence' to delivering secure and uninterrupted treatment, with engagements with biomedical expertise moderated in relation to a circulating culture of information scarcity. suggest that different technologies and practices actualise citizenship, including what they term informational biological citizenship, which refers to engagement with "specialized scientific and medical knowledge of one's condition" (p. 442). This form of citizenship closely echoes the emphasis on treatment literacy and expertise characterising the rise of 'expert' (cf. Kielman and Cataldo, 2010) and 'active' (cf. Barbot, 2006) patienthood in contemporary public health. Here, gathering, sharing and debating biomedical information on HIV is both a process of 'empowerment' of the patient vis-a-vis the authority of clinicians, and of 'responsibilisation' of the patient-citizen in the context of their condition.
Emphasis on treatment expertise has ramifications for patient-clinician discussions and for how treatment literacy may be imparted. For example, concerns about appearing 'foolish' or causing 'offense' to the doctor may manifest in patients' reticence to disclose their use of alternative medicines, as is reported to be the case with African men and women living with HIV and accessing UK national health services . Rather than experts on equal grounds with their care providers, patients may be informed just enough to know what not to say (Box 1, extr. 6).
Others too have observed how adherence discourse, as circulated in ART literacy sessions or other clinical encounters, can be disempowering. Here, competing forms of local knowledge can be discouraged, and everyday demands that affect treatment-taking discounted, often through the threat of treatment failure, and consequent sickness or death as a result of poor patient adherence .
The case of 'blood counts'
Particular attention has been paid to the meanings assigned to blood tests or 'counts', and their role in monitoring CD4 counts and viral load and the progression of HIV infection. The ethnographic work of in Uganda, for instance, focuses on CD4 counts as the "technological hook that clients can hang their hopes on" (p. 203), whilst the qualitative research of in the UK suggests that 'health' among people living with HIV is increasingly being measured by blood counts alone, turning the body into a "mere setting for action" (p. 110). Most such studies frame blood counts as technologies of discipline cf. Foucault, 1978) : while indicators of what the virus is doing, changes in HIV viral load can also reveal to the clinician what the patient might be doing. Holding the potential for unwanted disclosure and revelations about adherence, blood counts are clinical evidence indicating whether patients-clients are maintaining their part of a therapeutic deal ), acting as a kind of truth-telling device (O'Daniel, 2014; Box 1, extr.7).
Among people living with HIV interacting with public or welfare services, blood counts may be further seen as "gatekeepers" (Meinert et al., 2009, p. 206) , or stand for "biolegitimacy" (Marsland, 2012, p.472; cf. Fassin, 2001) , enabling access to additional forms of support, such as state benefits, housing, food staples and other goods. This system can work in opposing ways, however. In some settings, only those with very low CD4 counts (indicating advanced disease progression) may be eligible for welfare support, a potential disincentive to ART adherence in the context of otherwise scarce resources (cf. Leclerc-Madlala, 2006, in South Africa) . Elsewhere, only those with a 'good' CD4 count can prove that they are engaged with health services and stable 'enough' to access additional resources such as housing support (O'Daniel, 2014, in the US) .
In all cases, the meanings assigned to biomarkers -as vehicles or obstacles to other forms of support -exemplify how biomedicine is often able to shape specific subjectivities insofar as its promise stretches beyond clinical care itself . In the absence of further incentives to 'achieve viral suppression', patient engagement, especially in the context of poverty, can alternatively be mitigated by practices of deflection or indifference towards HIV health and treatment.
Not only disciplinary tools, biomarkers also shape interpretations of life and self with HIV . Blood counts can be seen as forms of 'abstract knowledge' about HIV, functioning as 'maps': where they rise as a result of ART, they "give a sense of direction, and ability to have plans and make priorities", turning however into "uncertainties and disorientation" when they do not rise as fast as expected (Meinert, et al, 2009, p. 204 ). Yet, such maps of an 'inside' are always framed by an 'outside': the interpretation of bio-information is situated in everyday social relations, indicating life situation and social condition.
In this way, blood counts chart socio-economic trajectories in relation to food, work and immunity . Food, for instance, is recommended for ARVs to work effectively and, in turn, ARVs are perceived to cause hunger (cf. Hardon et al., 2007; cf. Kalichman et al, 2015; cf. Kalofonos, 2010) . In the context of often otherwise rationed resources, CD4 counts do not drop when patients fail in their adherence, but when they are unable to purchase sufficient food to sustain adherence. Medical records thus tell stories of the alternate fortunes and misfortunes of those living with HIV, especially in precarious circumstances, just as they tell a story of the clinical and pharmaceutical care available to them at different times. In so doing, bio-information provides personal as well as political substantiation of the changing fate of people and their nations alike.
THERAPIES AND POLITICS
The ways in which ART is provided to, fought for, and accessed by people living with HIV constitute new forms of therapeutic citizenship . These intersect with extant relationships between self and state prior to HIV and ARVs, whilst at the same time "the way a state deals with AIDS reveals its statecraft" (Biehl, 2007, p. 11 ).
ART as a link between body and state(s)
The ethnographies of and document an emphasis on social justice and the redistribution of resources through which grassroots organisations effectively articulated their demands for ARVs in the early days of the Brazilian epidemic. Similarly, earlier claims to the right to ART in South Africa were characterised by dramatic competition with a strong nationalist discourse about 'authentic' African citizenship, infamously expressed through President Mbeki's AIDS denialism . According to , the struggle for ARVs in South Africa signalled both the rise of an international therapeutic citizenship and an engagement with emerging national identity issues post-apartheid (see also ).
Yet studies reviewed here note that the quality of HIV care often surpasses other domains of state health and social care, particularly in lower income settings where ART provision is funded by an uneven mixture of agencies, a phenomenon described by in Uganda as the "projectified" landscape of HIV care (p. 143). ART can frequently be distributed amidst a lack of other services, exposing a 'state' that is "pharmaceutically present but institutionally absent" (Biehl, 2007, p. 285) . This paradox has multiple divergent ramifications for patient-citizens: further collective engagement and demands on the one hand, but also a divisive pressure in the competition for resources on the other, or else a kind of apathy as the "pharmaceutical wellbeing" (Biehl, 2007, p. 302 ) afforded by ART is not enough to give rise to a socio-political sense of possibility.
For example, in the favelas of Brazil's Rio de Janeiro and in Kenya's national hospitals , patients may respond to the variation in the quality of the health services provided by developing a stronger sense of entitlement to better care beyond HIV. In this sense, therapeutic citizenship is enacted when people become more "sensitive to their individual rights" (Cataldo, 2008, p. 907 ; see also through ART provision and then seek to extend these to other areas of governmental services. Here, state provision of ARVs represents a link between individual 'politicised bodies' and the state, opening up the possibility of further interaction and involvement.
Free ART provision on the part of the state represents the inclusion of people otherwise socially and economically marginalised, for example those living in the South African townships , the patients of a non-governmental house of support in Brazil's Salvador de Bahia , or the residents in Rio de Janeiro's favelas who feel "privileged" because their government is both manufacturing and providing their HIV medications (Cataldo, 2008, p. 906) .
As people depend on governmental HIV programmes, however, their individual fate becomes inextricable from their national economy. A state of anxiety among people with no alternative means to HIV care can ensue (Box 2, extr.8). In the example of Serbia and Montenegro ), insecure availability of ART means patients worry daily about interruptions to their life-saving medications and the rumours circulating about ART rationing. Disengagement from the state and services, rather than the uptake of political action or engagement, manifests the anxiety produced by such uncertainty. Taking ART 'on' and 'off' is deemed more dangerous, and more difficult to cope with, than making a decision to avoid treatment altogether ; Box 2, extr.9).
ART and communities in the biomedicalisation of HIV
The gathering of activist communities around a shared biological condition is a core feature of biological and therapeutic citizenship . Whilst the seminal ethnographies of Nguyen in West Africa (2010) and Biehl in Brazil (2007) documented the early days of treatment activism following the development and distribution of ARVs, recent studies framed by these concepts concentrate on the increasingly 'individualising' features of biological citizenship under the influence of biomedical understandings of HIV as a 'manageable' and 'normalised' chronic condition following the scale-up of ART (cf. Moyer and Hardon, 2014) .
Studies we reviewed suggest that the accent placed on individual responsibility in the management of HIV is a prominent and consistent feature of current ART provision worldwide. Even where treatment activism was originally linked with rights-based discourses beyond healthcare (as in the case of South Africa), many observe a progressive reduction of the 'social problem' of HIV to an individualised concern (Biehl, 2007; . In high-income settings with free healthcare, such as the UK, neoliberal versions of HIV care are increasingly turned into a "depoliticised form of health consumerism" (Robins, 2005, p. 12) .
Grassroots NGOs become larger institutions in partnership with the state, and are increasingly oriented towards providing healthcare services rather than mobilising political activism cf. Seckinelgin, 2008) . Bureaucratisation and the need to attract funding through complex donor schemes set up hierarchies and weaken ties within communities ). Yet community organisations continue to be tasked with supporting those who 'fall out' of the patient/provider contract premised on the individualised 'management' of HIV via ART. When such 'failed' patients cannot be accommodated by NGOs, they fall out of the picture altogether .
As the "master status" of HIV identity is diluted through a (chiefly biomedical) emphasis on the normalisation of HIV as 'just another' chronic condition, some reason that the very bases for HIV biological citizenship comes undone and a fragile sense of HIV community creates hurdles for NGOs' response. Without HIV community, it becomes challenging to engage with 'HIV identity', considered central to a collective and relational drive towards 'responsibility' and adherence . The dissolution of ties of solidarity in the face of the putative normalisation of HIV thus makes it easier for some to be 'left behind', in varying degrees of social and moral isolation .
In settings where ART access is uneven or insecure, HIV care may become an outcome of competition between individuals in need rather than of collective actions . Different examples of 'triage' into therapy can be found in these studies: ART provided only to patients attending compulsory adherence-focused 'support' groups in South Africa ; ART provided only to those people who inject drugs in Russia who can demonstrate sufficient efforts to stop using drugs ; or amongst Ugandan patients assessed for their potential compliance through educational sessions and pill counts at the time of refill . When state offers of treatments are made contingent upon patients performing sufficient deservedness, a narrative of disempowered may be produced, far from the ideal of the 'engaged' and 'active' community of (biological) interest envisaged in citizenship claims cf. Rhodes et al., 2013) .
BIOSOCIALITY AND RESPONSIBILITY
As mentioned early on, biological and therapeutic citizenship theories -and the studies they frameare commonly connected to Paul Rabinow's conceptualisation of a nascent 'biosociality ' (1992a, 1992b) pertaining new forms of interaction and "belonging" (Nguyen, 2010, p. 178 ) based on shared biological characteristics. Biosociality refers to a process whereby people gather via the shared learning and experience of specific health conditions related to newly-identified objects in the body, such as genes or viruses, otherwise devoid of socio-cultural contextualisation. Specific technoscientific interventions pinpoint common biological traits, as in the case of drug treatments, drug regimens or clinical tests. HIV treatment, and not only HIV status, is thus productive of a new biosociality, as the practice of biomedicine and pharmaceutical technologies invite people to associate outside their everyday social relations and networks.
Going back to 'normal'? Returning to sociality from a new biology
In his account of treatment activism in South Africa, refers to a "new family" created through nascent biosocial communities linked to the experience of HIV positivity (p. 10), whilst describes the residents of a grassroots AIDS hospital in Salvador as a "biocommunity" (p. 324). Both authors note that biosociality emerges in the context of the stigmatisation of HIV, parallel to an observation made by regarding biological citizenship as a project of inclusion in response to discrimination (pp. 448-451). Gay activism in the context of the early AIDS epidemics in the US and Europe is most often cited as an example of mobilisation against fear, negative propaganda, and political and therapeutic neglect (cf. Epstein, 1996; .
Echoes can also be found in other literatures which frame HIV diagnosis as a 'turning point' through which people from marginalised groups find new meaning, direction and belonging. Although these studies do not necessarily refer to Rabinow's idea of biosociality, and are articulated as individual journeys of identity reconstruction around a stigmatised condition, they nonetheless point to forms of sociality emerging from a new biological condition of HIV seropositivity, which help to frame new understandings of self and community (cf. Berger, 2010; cf. Watkins Hays, Pittman-Gay and Beaman, 2012 ).
Yet many studies reviewed here unpack and contest the idea that a new sociality can be forged via HIV and ART. HIV stigma is not seen as a cohesive force for the stigmatised but as an ostracism leading to self-silencing. New forms of HIV-related sociality are thus described as a product of the reshaping of existing social ties rather than of biological connections.
For instance, argues that HIV and ARVs in Tanzania are insufficient to produce a new biosociality and that it is the shared experience of clinic and treatment practices that enables people with pre-existing links to gather under the recognised predicaments of HIV and ART. Similarly, observe that social connections which pre-date HIV diagnosis provide an "already-existing personalised web of influence" that people living with HIV in Uganda perceive as more salient than HIV bio-status alone as networks that can "be set in motion to get things done" (p. 149). In both cases, study participants lived in households affected by HIV wherein family relations were among the primary 'ties' in relation to life with HIV. They were also weaved into healthcare via personal acquaintances, not as 'individual' HIV patients, which suggests resourcefulness but also an inherent "fragility" as different people have unequal access to influential 'actors' (Whyte et al., 2013, p. 147) . In the creation of HIV-related sociality, pre-established social relationships may take precedence over new forms of 'bio'-social solidarity or connection. further explores how people in Tanzania wish to "return to a normal life" more than they wish to create new (bio)social networks (p. 166). Once health is 'restored' through ART, the main preoccupation is not to assume a new HIV identity or enter a new biosocial 'family', but rather to disclose one's status to as few people as possible, both to avoid stigmatisation and to attempt to seamlessly re-commence life post-HIV diagnosis (Box 3, extr.10). The quest for solidarity is thus overridden by the social risks involved in disclosure and, if ART produces any physical or visible side-effects, even treatment itself comes to be seen as threat to a return to normality.
People living with HIV in Tanzania express the desire first and foremost to develop ways to sustain a 'life worth living', embedded in social relations and exchange . Other studies add weight to this observation: Levy and Storeng note the need for income among HIV positive women in South Africa before they can engage in any discourse of 'positive living ' (2007) ; men engaged in peer-support in Cape Town want to work, earn money and resist the category of the "HIV vulnerable sufferer" Leavens, 2010, p. 1187) ; and Mattes finds that "dignity and social recognition" may constitute a core aspiration for some of his participants much more than the creation of a "pharmaceutical self" (2012, p. 81).
As engagement with biomedicine is 'deflected', HIV biosociality is edged to the periphery, only momentarily incorporated into primary forms of sociality. New forms of HIV sociality, although borne out of existing social ties rather than biology, nonetheless begin to modify existing social structures from the perspective of biology. Biosociality thus progressively intersects with, and might only eventually supersede, previous sociality over the long course, rather than in any immediate or automatic fashion .
Adherence and responsibility: towards whom?
An emphasis on personal responsibility frames the moral expectations placed on the therapeutic citizen's health behaviours . Social discourses of responsibility have also emerged from public health framings of the management of HIV risk, as moral counteraction to the negative sanctioning of people with HIV as 'deviant'. Biomedical responsibility especially is performed through adherence to ART, protecting the self through protecting immunity , reducing the risks of other illnesses, and minimising onward HIV transmission (cf. Persson, 2013) .
Testing, or 'knowing one's status', begins the process for "responsible citizens who have taken action" (Russell, Namukwaya, Zalwango and Seeley, 2015, p. 5) . Additional demonstrations of 'health-promoting' and responsible behaviours include abstaining from sex or using condoms, disclosing serostatus to partners, following guidance on 'positive living', advocating for those with the same condition, keeping informed, 'active' and engaged with healthcare and surrounding issues . Health workers are indeed often 'framing agents' instrumental in drawing the parameters of responsible citizenship .
Studies reviewed observe that responsibility is less an individual self-preserving endeavour than a "socio-moral phenomenon" (Mattes, 2012, p. 77) imbued with obligations towards the "hidden collective" of family, kin and community (Marsland, 2012, p. 474) . Adherence to treatment expresses responsibility as reciprocity towards the "consistent good will of potential helpers... required for survival" (Ware et al., 2009, p. 45) and preserves physical health necessary to perform income-generating and caring activities for the collective . Studies in South Africa cast adherence as a "pro-social behaviour furthering the common good" (Kagee et al., 2014, p. 107) , with doing one's best to stay healthy and to 'self-improve' via ART enacting responsibility towards communities. Likewise in Uganda, a collective therapeutic citizenship is "socially fashioned" by people living with HIV, based on responsible condition management and allegiances to healthcare workers and other patients alike (Russell et al., 2015, p. 8) .
Powerful associations between the need to be healthy and to care for others constitute a collective moral economy of adherence which, for , explains how people in sub-Saharan Africa manage to adhere as well as -or better than -those in higher income settings, in spite of the multitude of barriers they face (cf. Hardon et al., 2007) . Yet argues that ART programmes (in Tanzania) "shift the burden of responsibility for success... onto the shoulders of patients" despite the limits to responsible adherence in the context of poverty and survival (p. 161). Adherence and the importance of keeping the virus suppressed (now and in future) are threatened by the lack of opportunity for social and economic lives in the present.
Adherence then, is seen as a social (as well as a biomedical) technology requiring collective practice and commitment (from patients, healthcare workers, peer mentors, family members) , and responsibilisation may be articulated as constituting a means to provide and care for others. Responsibilisation can thus incorporate adherence but it extends further, as its reason-tobe is the preservation of social ties, above and beyond the preservation of health.
DISCUSSION
We have focused on social science studies that have engaged with ideas of biological and therapeutic citizenship in their accounts of HIV and its treatment. The literature reviewed is highly context-specific and grounded primarily in the global south (and Africa in particular), whilst in dialogue with discourses around global health. An overarching theme concerns the limits to the actualisation of citizenship in the context of competing social needs, alternative forms of knowledge and expertise, and structural relations, especially patterns of poverty and inequity.
Empirical case studies note tensions in the language and expectations of patient citizenship, the emphasis on individual responsibilisation, expertise, engagement and awareness of rights, in contrast with some of the situated experiences of HIV health and healthcare, particularly in lower income settings Niehaus, 2014) . This has led to a questioning of the scope of the theoretical frameworks of biological and therapeutic citizenship , also in instances where these are applied to conditions other than HIV (cf. Rhodes et al., 2013) . propose that the concept of 'therapeutic clientship' might more appropriately describe patron/client relations, embedded not only in funder/provider HIV-aid exchanges on a global scale, but also in provider/patient encounters in health systems characterised by scarcity, rationing, and conditional ART provision. Whilst a neoliberal reading of 'clientship' "suggests enlightened consumerism and user friendliness" (Whyte et al., 2013, p. 150) , in Uganda the patronage system of therapeutic clientship casts treatment provision as a profoundly social, and often tenuous, form of healthcare where there is little room for negotiating inclusive citizenship through treatment. This contrasts with the purported, idealised 'health contract' ) between HIV patients and their clinicians, which hints at shared duties and reciprocal rights in a supposedly neutral context of equal political grounds.
The limits of HIV citizenship and the 'health contract'
Whether offered on condition of compulsory treatment education and attendance at peer group discussions ), or whether non-coercive by emphasising "responsibilisation, consent and self-regulation" (Colvin et al., , p. 1183 , therapeutic clientship is implicitly unequal. Support group members can at times be treated as little more than "blank slates waiting to be filled with health and treatment information" (Mfecane, 2011, p. 133) . 'Reliable' and 'deviant' patients are separated to maximise resource allocation through an array of social and 'confessional' technologies , and the performance of the patient-citizen "comes to include the conditions and means for survival" (Kistner, 2009, p. 4) .
Therapeutic clientship reproduces a version of "healthcare as charity" in which "entitlements become concessions" (Biehl, 2007, p. 310) to those who display 'deservedness' . Reciprocity is required from the side of the patient-receiver who must give back through adherence first and foremost, but also through openness, patience, clinic attendance, gratitude and allegiance to the biomedical rationalities of ART (cf. Bernays et al., 2010; . Thus, as suggests, the only aspect of biological citizenship that is enacted in circumstances where people are entirely dependent on these forms of unequal HIV care, is the way in which patient-citizens are actually governed through biomedicine and made responsible not only in relation to their health, but also in relation to the state as a whole, "under the threat of the withdrawal of the means of life" (p. 1). Biological citizens rally behind a biological condition to seek re-inclusion under the protection (and provision) of the state rather than to have their biological rights recognised and needs met. When the state is 'absent', claims are made on global humanitarian grounds .
People living with HIV in many settings access healthcare in the context of otherwise disappearing public services infrastructures . But argues that protection and improvement of health and social care systems cannot be actualised through biological citizenship projects: they require broader political and economic struggles that are often beyond the capacities of patient-citizens, precisely because they depend so heavily on state ART provision.
Furthermore, biological inclusion (or re-inclusion via responsibilisation and adherence) runs parallel to social exclusion : the same people 'failed' by health and social care systems become those who cannot keep up their side of the new health contract. Examples of this abound in the studies reviewed, describing the conditions of those who are homeless (O' Daniel, 2014) , have substance use issues that preclude their access to ART , are 'troublesome' in instances of communal institutional living , or exist on the margins, in one way or another, to the extent that they 'fall out' of healthcare relations despite being in utmost need .
Perhaps the limits of citizenship frameworks for understanding ART and care engagement are to be found in the application of the theories to empirical contexts and examples other than those for whom they were originally conceived. For example, concept of biological citizenship illuminates clearly the trajectory of early gay activism in relation to the US HIV/AIDS epidemic and successfully links this to the mobilisation of other, new, biosocial communities, for example around genetic conditions. It may lose some of its analytical power vis-à-vis landscapes where health systems and techno-science are barely visible.
Similarly, therapeutic citizenship might more accurately describe the biopolitical repercussions on local lives of the introduction of ARVs at a global scale. It addresses that very momentum in the shift in sovereignty beyond national health systems, tracking HIV and AIDS as an extraordinary global health experiment ushering in and transposing a whole apparatus across settings and health conditions. It may not stretch to encompass all forms of HIV and ART engagements and disengagements throughout the pandemic.
CONCLUSION
Theories of patient citizenship both herald and critique the concept of 'cascade of care' and its components. The progression of the cascade of care can be seen to represent a clear pathway to HIV biological citizenship, with viral suppression projected as the objective measurement of success and hope of HIV citizens. Multiple constituents of biological citizenship are implicated in the care engagement pivotal to the cascade, including informational citizenship, patient rights, and moral values surrounding responsibilisation.
Our synthesis suggests that further research about emerging forms of patient citizenship linked to care and pharmaceutical demands would be greatly relevant in the context of competition for public funding and expenditures. Citizenship theories may also need to be 'tested' with empirical studies regarding rationing and treatment reductions, at a time when engagement and retention in care is increasingly articulated along the lines of cost effectiveness debates in health systems (Nosyk et al., 2014; Stover et al., 2014) . Furthermore, as well as their health benefits, the added prevention effects of HIV viral suppression also represent significant cost savings (Gupta, Williams and Montaner, 2014) . Against this background, it will be important to analyse how biological citizens may be increasingly made individually responsible for more than their own health. Viral suppression and related biomarkers are a universally recognised language in biomedicine , which lends this clinical information certain capital . The 'biological efficacy' of a clinic in retaining patient cohorts on treatment (Nguyen, 2005, p. 139 ) is intertwined with collective evidence of the functioning of national health systems. The notion of biological efficacy is thus useful and relevant to analyses of care cascade frameworks, since these are already in use to track and model national epidemics and to inform further investment in treatment-asprevention strategies in different regions. The literature reviewed here cautions that steps in the cascade, which are becoming globally recognisable characteristics, can obfuscate stark structural inequalities, pay insufficient attention to local context, and describe little of the linkage between initiatives that can achieve potentially more meaningful health outcomes for people living with HIV and their broader health needs and rights. Table 1 Core theoretical papers
Authors
Year Title 
BOX 1

Deflecting biomedicine
(1) One of the HIV doctors in Alcano's ethnography in Milan says: 'a strong patient' is 'a patient who complies with prescriptions, who takes the medicines methodically ' (2009, p. 121) . One of his patients, a positive male construction worker, asserts instead: 'My doctor always repeats that I have to stay strong and take the medicine. I tried to explain to him that what makes me strong kind of kills me at work' (Alcano, 2009, p. 125) .
Situated rationality of ART and adherence
(2) As the primary provider of the household, Paolo -a construction worker from Milan -feels that ART side-effects clash with his primary necessities: 'I have a family to support and my wife does not have a job. I need to go to work and provide for basically everything. And when you are in my situation your arms better be strong and working, otherwise you're in trouble' (Alcano, 2009, p. 127) .
(3) Leo -another construction worker in Alcano's ethnography in Milan -describes his 'steering' strategies about treatment-taking as: 'getting comfortable in the space between myself and my doctors' (Alcano, 2009, p. 124) . Case study of competing priorities (5) Mattes' (2011) case study is the story of Haruna, an HIV positive male construction worker in Tanga (Tanzania) recently widowed. He is concerned his in-laws will refuse to contribute to the medical care of his new-born son if he discloses the mother's death due to HIV and his own HIV status. Haruna's need for both treatment and support is impossibly balanced, he cannot "harmonize the rigid treatment regime with his working conditions" (p. 170) but also has to disclose and "risk his relatives' solidarity... to ensure adequate medical care for his new-born son" (p. 171).
Non-engagement
Treatment literacy and expertise
(6) 'I believe that if you are talking to someone who is educated medically, they won't understand -'you are using herbs, what do you need to use herbs for?' So I thought they wouldn't understand why I wanted to use the herbs... So that's why I didn't tell them' (Zimbabwean participant in Thomas, Aggleton and Anderson, 2010, p. 740 ). (7) As Lady E, one of the positive African American women in O'Daniel's ethnography in North Carolina (US), explains: 'That's on you to care about taking those meds. Let's keep it real. Just call it whatever the hell it really is -'lazy' or 'don't give a damn'. This is the truth of your life. Take the medication or don't... they'll know because they [doctors'] read it [the truth] in your blood ' (2014, p. 328 ).
Blood counts as truth telling
BOX 2
Insecurity and disengagement (8) As expressed here by Edilson, one of Brazilian participants: 'I am afraid that we could be in a situation where treatment is not available any more, and if there is a lack of treatment it would be fatal, death would be the only outcome . . . I'm scared, because I have seen many weaknesses in the government, and I'm scared that it could be another failure' (p. 908).
(9) Insecure availability of ART means participants in qualitative study in Serbia and Montenegro discuss how they 'have constantly the worry about what happens today and after today', 'live from one day to another', and complain that: 'the talk with people and in the media is always these terrifying headlines, like: 'there won't be any medicines'; or 'there won't be enough money for HIV treatment' (p. 317).
BOX 3
Returning to sociality (10) Maria, a participant in ethnography in rural Tanzania, states: 'until there is some kind of profit in living openly with HIV, I am going to keep it a secret ' (2012, p. 470 ; also echoed by participants in Mfecane, 2011 in South Africa) .
